English
Segment disclosures
Company overviewMarkel Corporation
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
Disposition Gain · Markel Ventures
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=mkl:DispositionGainMember;us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-09-30 | 0 | USD | 20231101 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 0 | USD | 20230426 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 0 | USD | 20231101 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 0 | USD | 20230426 | Open filing evidence |
Disposition Gain · Markel Ventures Operations
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=mkl:DispositionGainMember;us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesOperationsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-06-30 | 0 | USD | 20220802 | Open filing evidence |
Disposition Gain · Other
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=mkl:DispositionGainMember;us-gaap:StatementBusinessSegmentsAxis=mkl:OtherMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-09-30 | 16923000 | USD | 20231101 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 16923000 | USD | 20230802 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 16923000 | USD | 20230802 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 0 | USD | 20230426 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 225828000 | USD | 20230217 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 107293000 | USD | 20231101 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 0 | USD | 20230802 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 107293000 | USD | 20230802 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 107293000 | USD | 20230426 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 0 | USD | 20230217 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 0 | USD | 20221101 | Open filing evidence |
Investment Management · Revenue From Contract With Customer · Markel Ventures
Product Or Service · Concentration Risk By Benchmark · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=mkl:InvestmentManagementMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 0 | USD | 20240501 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 0 | USD | 20240501 | Open filing evidence |
Investment Management · Revenue From Contract With Customer · Markel Ventures Operations
Product Or Service · Concentration Risk By Benchmark · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=mkl:InvestmentManagementMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesOperationsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-07-01 – 2022-09-30 | 0 | USD | 20221101 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 0 | USD | 20221101 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 0 | USD | 20221101 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 0 | USD | 20221101 | Open filing evidence |
Investment Management · Revenue From Contract With Customer · Other Insurance Operations
Product Or Service · Concentration Risk By Benchmark · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=mkl:InvestmentManagementMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:OtherInsuranceOperationsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 19936000 | USD | 20240501 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 10459000 | USD | 20240501 | Open filing evidence |
Investment Management · Revenue From Contract With Customer · Other
Product Or Service · Concentration Risk By Benchmark · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=mkl:InvestmentManagementMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:OtherMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-03-31 | 10459000 | USD | 20230426 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 15641000 | USD | 20221101 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 55197000 | USD | 20221101 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 19228000 | USD | 20230426 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 20571000 | USD | 20221101 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 57693000 | USD | 20221101 | Open filing evidence |
Investment Management · Markel Ventures Operations · Revenue From Contract With Customer
Product Or Service · Statement Business Segments · Concentration Risk By Benchmark
Source dimensions
srt:ProductOrServiceAxis=mkl:InvestmentManagementMember;us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesOperationsMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-03-31 | 0 | USD | 20220426 | Open filing evidence |
Management Fees · Revenue From Contract With Customer · Consumer And Other
Product Or Service · Concentration Risk By Benchmark · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=mkl:ManagementFeesMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:ConsumerAndOtherMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 0 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 0 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 0 | USD | 20260428 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 0 | USD | 20260226 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 0 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 0 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 0 | USD | 20260428 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 0 | USD | 20260226 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 0 | USD | 20260226 | Open filing evidence |
Management Fees · Revenue From Contract With Customer · Corporate Operations
Product Or Service · Concentration Risk By Benchmark · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=mkl:ManagementFeesMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:CorporateOperationsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 0 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 0 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 0 | USD | 20260428 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 0 | USD | 20260226 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 0 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 0 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 0 | USD | 20260428 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 0 | USD | 20260226 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 0 | USD | 20260226 | Open filing evidence |
Management Fees · Revenue From Contract With Customer · Financial
Product Or Service · Concentration Risk By Benchmark · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=mkl:ManagementFeesMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:FinancialMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 37658000 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 79212000 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 41554000 | USD | 20260428 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 161890000 | USD | 20260226 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 30340000 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 85790000 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 29582000 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 55450000 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 25868000 | USD | 20260428 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 97226000 | USD | 20260226 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 25858000 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 68340000 | USD | 20251029 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 99509000 | USD | 20260226 | Open filing evidence |
Management Fees · Revenue From Contract With Customer · Industrial
Product Or Service · Concentration Risk By Benchmark · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=mkl:ManagementFeesMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:IndustrialMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 0 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 0 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 0 | USD | 20260428 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 0 | USD | 20260226 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 0 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 0 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 0 | USD | 20260428 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 0 | USD | 20260226 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 0 | USD | 20260226 | Open filing evidence |
Management Fees · Revenue From Contract With Customer · Markel Insurance
Product Or Service · Concentration Risk By Benchmark · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=mkl:ManagementFeesMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelInsuranceMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 0 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 0 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 0 | USD | 20260428 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 0 | USD | 20260226 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 0 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 0 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 0 | USD | 20260428 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 0 | USD | 20260226 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 0 | USD | 20260226 | Open filing evidence |
Management Fees · Revenue From Contract With Customer · Markel Ventures
Product Or Service · Concentration Risk By Benchmark · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=mkl:ManagementFeesMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-04-01 – 2025-06-30 | 0 | USD | 20250730 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 0 | USD | 20250730 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 0 | USD | 20250430 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 0 | USD | 20250224 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 0 | USD | 20241030 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 0 | USD | 20241030 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 0 | USD | 20250730 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 0 | USD | 20250730 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 0 | USD | 20250430 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 0 | USD | 20250224 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 0 | USD | 20241030 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 0 | USD | 20241030 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 0 | USD | 20250224 | Open filing evidence |
Management Fees · Revenue From Contract With Customer · Other
Product Or Service · Concentration Risk By Benchmark · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=mkl:ManagementFeesMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:OtherMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-04-01 – 2025-06-30 | 29582000 | USD | 20250730 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 55450000 | USD | 20250730 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 25868000 | USD | 20250430 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 97226000 | USD | 20250224 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 25858000 | USD | 20241030 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 68340000 | USD | 20241030 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 22546000 | USD | 20250730 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 42482000 | USD | 20250730 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 19936000 | USD | 20250430 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 99509000 | USD | 20250224 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 44204000 | USD | 20241030 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 76108000 | USD | 20241030 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 79209000 | USD | 20250224 | Open filing evidence |
Other Revenues · Markel Ventures Operations
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=mkl:OtherRevenuesMember;us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesOperationsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-07-01 – 2022-09-30 | 25950000 | USD | 20221101 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 84800000 | USD | 20221101 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 27370000 | USD | 20220802 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 58850000 | USD | 20220802 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 82824000 | USD | 20221101 | Open filing evidence |
Other Revenues · Other
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=mkl:OtherRevenuesMember;us-gaap:StatementBusinessSegmentsAxis=mkl:OtherMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-03-31 | 658000 | USD | 20230426 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 118000 | USD | 20221101 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 724000 | USD | 20221101 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 281000 | USD | 20220802 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 606000 | USD | 20220802 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 7001000 Restated | USD | 20230426 | Open filing evidence |
Program Services And Other Fronting · Markel Ventures
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=mkl:ProgramServicesAndOtherFrontingMember;us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-07-01 – 2023-09-30 | 0 | USD | 20231101 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 0 | USD | 20231101 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 0 | USD | 20231101 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 0 | USD | 20231101 | Open filing evidence |
Program Services And Other Fronting · Markel Ventures Operations
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=mkl:ProgramServicesAndOtherFrontingMember;us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesOperationsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-04-01 – 2022-06-30 | 0 | USD | 20220802 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 0 | USD | 20220802 | Open filing evidence |
Program Services And Other Fronting · Other
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=mkl:ProgramServicesAndOtherFrontingMember;us-gaap:StatementBusinessSegmentsAxis=mkl:OtherMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-07-01 – 2023-09-30 | 39499000 | USD | 20231101 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 105952000 | USD | 20231101 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 28890000 | USD | 20230426 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 40033000 | USD | 20231101 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 103096000 | USD | 20231101 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 29731000 | USD | 20220802 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 63063000 | USD | 20220802 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 33332000 | USD | 20230426 | Open filing evidence |
Program Servicesand Other · Markel Ventures Operations
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=mkl:ProgramServicesandOtherMember;us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesOperationsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-01-01 – 2021-12-31 | 0 | USD | 20220218 | Open filing evidence |
Program Servicesand Other · Other
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=mkl:ProgramServicesandOtherMember;us-gaap:StatementBusinessSegmentsAxis=mkl:OtherMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-01-01 – 2021-12-31 | 123823000 | USD | 20220218 | Open filing evidence |
Services · Revenue From Contract With Customer · Consumer And Other
Product Or Service · Concentration Risk By Benchmark · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=mkl:ServicesMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:ConsumerAndOtherMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 95562000 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 182920000 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 87358000 | USD | 20260428 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 353403000 | USD | 20260226 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 91598000 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 258732000 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 88693000 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 167134000 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 78441000 | USD | 20260428 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 314439000 | USD | 20260226 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 74977000 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 233874000 | USD | 20251029 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 325703000 | USD | 20260226 | Open filing evidence |
Services · Revenue From Contract With Customer · Corporate Operations
Product Or Service · Concentration Risk By Benchmark · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=mkl:ServicesMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:CorporateOperationsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 0 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 0 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 0 | USD | 20260428 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 0 | USD | 20260226 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 0 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 0 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 0 | USD | 20260428 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 0 | USD | 20260226 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 0 | USD | 20260226 | Open filing evidence |
Services · Revenue From Contract With Customer · Financial
Product Or Service · Concentration Risk By Benchmark · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=mkl:ServicesMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:FinancialMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 110000 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 370000 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 260000 | USD | 20260428 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 1275000 | USD | 20260226 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 441000 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 1160000 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 249000 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 719000 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 470000 | USD | 20260428 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 828000 | USD | 20260226 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | -352000 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 476000 | USD | 20251029 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 816000 | USD | 20260226 | Open filing evidence |
Services · Revenue From Contract With Customer · Industrial
Product Or Service · Concentration Risk By Benchmark · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=mkl:ServicesMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:IndustrialMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 585115000 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 1042380000 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 457265000 | USD | 20260428 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 2171322000 | USD | 20260226 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 588148000 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 1578137000 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 560095000 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 989989000 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 429894000 | USD | 20260428 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 2001383000 | USD | 20260226 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 536085000 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 1445797000 | USD | 20251029 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 1937158000 | USD | 20260226 | Open filing evidence |
Services · Revenue From Contract With Customer · Markel Insurance
Product Or Service · Concentration Risk By Benchmark · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=mkl:ServicesMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelInsuranceMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 1581000 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 3123000 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 1542000 | USD | 20260428 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 10521000 | USD | 20260226 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 1199000 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 4748000 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 1604000 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 3549000 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 1945000 | USD | 20260428 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 9365000 | USD | 20260226 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 2593000 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 6313000 | USD | 20251029 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 9525000 | USD | 20260226 | Open filing evidence |
Services · Revenue From Contract With Customer · Markel Ventures
Product Or Service · Concentration Risk By Benchmark · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=mkl:ServicesMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-04-01 – 2025-06-30 | 648788000 | USD | 20250730 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 1157123000 | USD | 20250730 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 508335000 | USD | 20250430 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 2315822000 | USD | 20250224 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 611062000 | USD | 20241030 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 1679671000 | USD | 20241030 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 570319000 | USD | 20250730 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 1068609000 | USD | 20250730 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 498290000 | USD | 20250430 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 2262861000 | USD | 20250224 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 595459000 | USD | 20241030 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 1651339000 | USD | 20241030 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 2184196000 | USD | 20250224 | Open filing evidence |
Services · Revenue From Contract With Customer · Markel Ventures Operations
Product Or Service · Concentration Risk By Benchmark · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=mkl:ServicesMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesOperationsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-07-01 – 2022-09-30 | 614519000 | USD | 20221101 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 1633353000 | USD | 20221101 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 569385000 | USD | 20220802 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 1018834000 | USD | 20220802 | Open filing evidence |
Services · Revenue From Contract With Customer · Other
Product Or Service · Concentration Risk By Benchmark · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=mkl:ServicesMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:OtherMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-04-01 – 2025-06-30 | 1853000 | USD | 20250730 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 4268000 | USD | 20250730 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 2415000 | USD | 20250430 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 10193000 | USD | 20250224 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 2241000 | USD | 20241030 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 6789000 | USD | 20241030 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 2415000 | USD | 20250730 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 4548000 | USD | 20250730 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 2133000 | USD | 20250430 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 10341000 | USD | 20250224 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 2904000 | USD | 20241030 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 7542000 | USD | 20241030 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 2854000 | USD | 20230426 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 43875000 | USD | 20250224 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 11529000 | USD | 20221101 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 41547000 | USD | 20221101 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 8450000 | USD | 20220802 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 30018000 | USD | 20220802 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 21568000 | USD | 20230426 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 134850000 | USD | 20240223 | Open filing evidence |
Services · Markel Ventures · Revenue From Contract With Customer
Product Or Service · Statement Business Segments · Concentration Risk By Benchmark
Source dimensions
srt:ProductOrServiceAxis=mkl:ServicesMember;us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-12-31 | 2262861000 | USD | 20240223 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 485662000 | USD | 20230426 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 2184196000 | USD | 20240223 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 449449000 | USD | 20230426 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 1837029000 | USD | 20240223 | Open filing evidence |
Services · Markel Ventures Operations · Revenue From Contract With Customer
Product Or Service · Statement Business Segments · Concentration Risk By Benchmark
Source dimensions
srt:ProductOrServiceAxis=mkl:ServicesMember;us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesOperationsMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-03-31 | 449449000 | USD | 20220426 | Open filing evidence |
Services · Other · Revenue From Contract With Customer
Product Or Service · Statement Business Segments · Concentration Risk By Benchmark
Source dimensions
srt:ProductOrServiceAxis=mkl:ServicesMember;us-gaap:StatementBusinessSegmentsAxis=mkl:OtherMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-04-01 – 2023-06-30 | 1784000 | USD | 20230802 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 4638000 | USD | 20230802 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 8450000 | USD | 20230802 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 30018000 | USD | 20230802 | Open filing evidence |
Product · Revenue From Contract With Customer · Consumer And Other
Product Or Service · Concentration Risk By Benchmark · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:ConsumerAndOtherMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 437498000 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 612048000 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 174550000 | USD | 20260428 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 957885000 | USD | 20260226 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 181628000 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 795614000 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 422226000 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 613986000 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 191760000 | USD | 20260428 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 944671000 | USD | 20260226 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 173351000 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 779035000 | USD | 20251029 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 858332000 | USD | 20260226 | Open filing evidence |
Product · Revenue From Contract With Customer · Corporate Operations
Product Or Service · Concentration Risk By Benchmark · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:CorporateOperationsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 0 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 0 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 0 | USD | 20260428 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 0 | USD | 20260226 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 0 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 0 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 0 | USD | 20260428 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 0 | USD | 20260226 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 0 | USD | 20260226 | Open filing evidence |
Product · Revenue From Contract With Customer · Financial
Product Or Service · Concentration Risk By Benchmark · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:FinancialMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 0 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 0 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 0 | USD | 20260428 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 0 | USD | 20260226 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 0 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 0 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 0 | USD | 20260428 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 0 | USD | 20260226 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 0 | USD | 20260226 | Open filing evidence |
Product · Revenue From Contract With Customer · Industrial
Product Or Service · Concentration Risk By Benchmark · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:IndustrialMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 414462000 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 803950000 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 389488000 | USD | 20260428 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 1591519000 | USD | 20260226 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 417986000 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 1197798000 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 417455000 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 779812000 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 362357000 | USD | 20260428 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 1662910000 | USD | 20260226 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 432120000 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 1261664000 | USD | 20251029 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 1628722000 | USD | 20260226 | Open filing evidence |
Product · Revenue From Contract With Customer · Markel Insurance
Product Or Service · Concentration Risk By Benchmark · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelInsuranceMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 0 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 0 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 0 | USD | 20260428 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 0 | USD | 20260226 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 0 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 0 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 0 | USD | 20260428 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 0 | USD | 20260226 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 0 | USD | 20260226 | Open filing evidence |
Product · Revenue From Contract With Customer · Markel Ventures
Product Or Service · Concentration Risk By Benchmark · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-04-01 – 2025-06-30 | 839681000 | USD | 20250730 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 1393798000 | USD | 20250730 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 554117000 | USD | 20250430 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 2607581000 | USD | 20250224 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 605471000 | USD | 20241030 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 2040699000 | USD | 20241030 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 840636000 | USD | 20250730 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 1435228000 | USD | 20250730 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 594592000 | USD | 20250430 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 2487054000 | USD | 20250224 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 585707000 | USD | 20241030 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 1921773000 | USD | 20241030 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 770171000 | USD | 20240731 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 1336066000 | USD | 20240731 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 2379399000 | USD | 20250224 | Open filing evidence |
Product · Revenue From Contract With Customer · Other
Product Or Service · Concentration Risk By Benchmark · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:OtherMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-04-01 – 2025-06-30 | 0 | USD | 20250730 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 0 | USD | 20250730 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 0 | USD | 20250430 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 0 | USD | 20250224 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 0 | USD | 20241030 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 0 | USD | 20241030 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 0 | USD | 20250730 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 0 | USD | 20250730 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 0 | USD | 20250430 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 0 | USD | 20250224 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 0 | USD | 20241030 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 0 | USD | 20241030 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 0 | USD | 20240731 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 0 | USD | 20240731 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 0 | USD | 20250224 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 0 | USD | 20220426 | Open filing evidence |
Product · Other · Revenue From Contract With Customer
Product Or Service · Statement Business Segments · Concentration Risk By Benchmark
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:StatementBusinessSegmentsAxis=mkl:OtherMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 0 | USD | 20230217 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 0 | USD | 20230217 | Open filing evidence |
Revenue From Contract With Customer · Investment Management · Other
Concentration Risk By Benchmark · Product Or Service · Statement Business Segments
Source dimensions
us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;srt:ProductOrServiceAxis=mkl:InvestmentManagementMember;us-gaap:StatementBusinessSegmentsAxis=mkl:OtherMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-04-01 – 2024-06-30 | 22546000 | USD | 20240731 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 42482000 | USD | 20240731 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 99509000 | USD | 20240223 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 21445000 | USD | 20240731 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 31904000 | USD | 20240731 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 79209000 | USD | 20240223 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 86257000 | USD | 20240223 | Open filing evidence |
Revenue From Contract With Customer · Services · Markel Ventures
Concentration Risk By Benchmark · Product Or Service · Statement Business Segments
Source dimensions
us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;srt:ProductOrServiceAxis=mkl:ServicesMember;us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 498290000 | USD | 20240501 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 597512000 | USD | 20231101 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 1652187000 | USD | 20231101 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 486481000 | USD | 20240501 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 594717000 | USD | 20231101 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 1593946000 | USD | 20231101 | Open filing evidence |
Revenue From Contract With Customer · Services · Other Insurance Operations
Concentration Risk By Benchmark · Product Or Service · Statement Business Segments
Source dimensions
us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;srt:ProductOrServiceAxis=mkl:ServicesMember;us-gaap:StatementBusinessSegmentsAxis=mkl:OtherInsuranceOperationsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 2133000 | USD | 20240501 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 2854000 | USD | 20240501 | Open filing evidence |
Revenue From Contract With Customer · Services · Other
Concentration Risk By Benchmark · Product Or Service · Statement Business Segments
Source dimensions
us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;srt:ProductOrServiceAxis=mkl:ServicesMember;us-gaap:StatementBusinessSegmentsAxis=mkl:OtherMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-04-01 – 2024-06-30 | 2415000 | USD | 20240731 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 4548000 | USD | 20240731 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 2904000 | USD | 20231101 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 7542000 | USD | 20231101 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 1784000 | USD | 20240731 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 4638000 | USD | 20240731 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 11529000 | USD | 20231101 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 41547000 | USD | 20231101 | Open filing evidence |
Revenue From Contract With Customer · Product · Markel Ventures
Concentration Risk By Benchmark · Product Or Service · Statement Business Segments
Source dimensions
us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 594592000 | USD | 20240501 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 585707000 | USD | 20231101 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 1921773000 | USD | 20231101 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 565895000 | USD | 20240501 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 575277000 | USD | 20231101 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 1809276000 | USD | 20231101 | Open filing evidence |
Revenue From Contract With Customer · Product · Other
Concentration Risk By Benchmark · Product Or Service · Statement Business Segments
Source dimensions
us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:StatementBusinessSegmentsAxis=mkl:OtherMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-12-31 | 0 | USD | 20240223 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 0 | USD | 20231101 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 0 | USD | 20231101 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 0 | USD | 20240223 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 0 | USD | 20231101 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 0 | USD | 20231101 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 0 | USD | 20240223 | Open filing evidence |
Revenue From Contract With Customer · Consumer And Other
Concentration Risk By Benchmark · Statement Business Segments
Source dimensions
us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:ConsumerAndOtherMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 277603000 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 1072571000 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
| 2026-04-01 – 2026-06-30 | 533060000 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 794968000 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 261908000 | USD | 20260428 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 1311288000 | USD | 20260226 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 273226000 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 1054346000 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 510919000 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 781120000 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 270201000 | USD | 20260428 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 1259110000 | USD | 20260226 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 248328000 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 1012909000 | USD | 20251029 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 1184035000 | USD | 20260226 | Open filing evidence |
Revenue From Contract With Customer · Consumer And Other · Management Fees
Concentration Risk By Benchmark · Statement Business Segments · Product Or Service
Source dimensions
us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:ConsumerAndOtherMember;srt:ProductOrServiceAxis=mkl:ManagementFeesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 0 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 0 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 0 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 0 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
Revenue From Contract With Customer · Consumer And Other · Services
Concentration Risk By Benchmark · Statement Business Segments · Product Or Service
Source dimensions
us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:ConsumerAndOtherMember;srt:ProductOrServiceAxis=mkl:ServicesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 97555000 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 280475000 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 91598000 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 258732000 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
Revenue From Contract With Customer · Consumer And Other · Product
Concentration Risk By Benchmark · Statement Business Segments · Product Or Service
Source dimensions
us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:ConsumerAndOtherMember;srt:ProductOrServiceAxis=us-gaap:ProductMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 180048000 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 792096000 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 181628000 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 795614000 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
Revenue From Contract With Customer · Corporate Operations
Concentration Risk By Benchmark · Statement Business Segments
Source dimensions
us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:CorporateOperationsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 0 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 0 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
| 2026-04-01 – 2026-06-30 | 0 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 0 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 0 | USD | 20260428 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 0 | USD | 20260226 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 0 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 0 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 0 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 0 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 0 | USD | 20260428 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 0 | USD | 20260226 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 0 | USD | 20260226 | Open filing evidence |
Revenue From Contract With Customer · Corporate Operations · Management Fees
Concentration Risk By Benchmark · Statement Business Segments · Product Or Service
Source dimensions
us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:CorporateOperationsMember;srt:ProductOrServiceAxis=mkl:ManagementFeesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 0 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 0 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 0 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 0 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
Revenue From Contract With Customer · Corporate Operations · Services
Concentration Risk By Benchmark · Statement Business Segments · Product Or Service
Source dimensions
us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:CorporateOperationsMember;srt:ProductOrServiceAxis=mkl:ServicesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 0 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 0 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 0 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 0 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
Revenue From Contract With Customer · Corporate Operations · Product
Concentration Risk By Benchmark · Statement Business Segments · Product Or Service
Source dimensions
us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:CorporateOperationsMember;srt:ProductOrServiceAxis=us-gaap:ProductMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 0 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 0 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 0 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 0 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
Revenue From Contract With Customer · Financial
Concentration Risk By Benchmark · Statement Business Segments
Source dimensions
us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:FinancialMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 42273000 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 121855000 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
| 2026-04-01 – 2026-06-30 | 37768000 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 79582000 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 41814000 | USD | 20260428 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 163165000 | USD | 20260226 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 30781000 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 86950000 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 29831000 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 56169000 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 26338000 | USD | 20260428 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 98054000 | USD | 20260226 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 25506000 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 68816000 | USD | 20251029 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 100325000 | USD | 20260226 | Open filing evidence |
Revenue From Contract With Customer · Financial · Management Fees
Concentration Risk By Benchmark · Statement Business Segments · Product Or Service
Source dimensions
us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:FinancialMember;srt:ProductOrServiceAxis=mkl:ManagementFeesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 42198000 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 121410000 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 30340000 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 85790000 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
Revenue From Contract With Customer · Financial · Services
Concentration Risk By Benchmark · Statement Business Segments · Product Or Service
Source dimensions
us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:FinancialMember;srt:ProductOrServiceAxis=mkl:ServicesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 75000 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 445000 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 441000 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 1160000 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
Revenue From Contract With Customer · Financial · Product
Concentration Risk By Benchmark · Statement Business Segments · Product Or Service
Source dimensions
us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:FinancialMember;srt:ProductOrServiceAxis=us-gaap:ProductMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 0 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 0 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 0 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 0 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
Revenue From Contract With Customer · Industrial
Concentration Risk By Benchmark · Statement Business Segments
Source dimensions
us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:IndustrialMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 1130229000 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 2976559000 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
| 2026-04-01 – 2026-06-30 | 999577000 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 1846330000 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 846753000 | USD | 20260428 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 3762841000 | USD | 20260226 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 1006134000 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 2775935000 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 977550000 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 1769801000 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 792251000 | USD | 20260428 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 3664293000 | USD | 20260226 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 968205000 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 2707461000 | USD | 20251029 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 3565880000 | USD | 20260226 | Open filing evidence |
Revenue From Contract With Customer · Industrial · Management Fees
Concentration Risk By Benchmark · Statement Business Segments · Product Or Service
Source dimensions
us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:IndustrialMember;srt:ProductOrServiceAxis=mkl:ManagementFeesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 0 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 0 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 0 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 0 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
Revenue From Contract With Customer · Industrial · Services
Concentration Risk By Benchmark · Statement Business Segments · Product Or Service
Source dimensions
us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:IndustrialMember;srt:ProductOrServiceAxis=mkl:ServicesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 651348000 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 1693728000 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 588148000 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 1578137000 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
Revenue From Contract With Customer · Industrial · Product
Concentration Risk By Benchmark · Statement Business Segments · Product Or Service
Source dimensions
us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:IndustrialMember;srt:ProductOrServiceAxis=us-gaap:ProductMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 478881000 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 1282831000 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 417986000 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 1197798000 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
Revenue From Contract With Customer · Markel Insurance
Concentration Risk By Benchmark · Statement Business Segments
Source dimensions
us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelInsuranceMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 3136000 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 6259000 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
| 2026-04-01 – 2026-06-30 | 1581000 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 3123000 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 1542000 | USD | 20260428 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 10521000 | USD | 20260226 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 1199000 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 4748000 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 1604000 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 3549000 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 1945000 | USD | 20260428 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 9365000 | USD | 20260226 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 2593000 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 6313000 | USD | 20251029 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 9525000 | USD | 20260226 | Open filing evidence |
Revenue From Contract With Customer · Markel Insurance · Management Fees
Concentration Risk By Benchmark · Statement Business Segments · Product Or Service
Source dimensions
us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelInsuranceMember;srt:ProductOrServiceAxis=mkl:ManagementFeesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 0 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 0 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 0 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 0 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
Revenue From Contract With Customer · Markel Insurance · Services
Concentration Risk By Benchmark · Statement Business Segments · Product Or Service
Source dimensions
us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelInsuranceMember;srt:ProductOrServiceAxis=mkl:ServicesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 3136000 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 6259000 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 1199000 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 4748000 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
Revenue From Contract With Customer · Markel Insurance · Product
Concentration Risk By Benchmark · Statement Business Segments · Product Or Service
Source dimensions
us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelInsuranceMember;srt:ProductOrServiceAxis=us-gaap:ProductMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 0 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 0 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 0 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 0 | USD | 2026-10-28 · 20:36:51.000Z | Open filing evidence |
Revenue From Contract With Customer · Markel Ventures
Concentration Risk By Benchmark · Statement Business Segments
Source dimensions
us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-04-01 – 2025-06-30 | 1488469000 | USD | 20250730 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 2550921000 | USD | 20250730 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 1062452000 | USD | 20250430 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 4923403000 | USD | 20250224 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 1216533000 | USD | 20241030 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 3720370000 | USD | 20241030 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 1410955000 | USD | 20250730 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 2503837000 | USD | 20250730 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 1092882000 | USD | 20250430 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 4749915000 | USD | 20250224 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 1181166000 Restated | USD | 20241030 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 3573112000 Restated | USD | 20241030 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 1339570000 | USD | 20240731 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 2391946000 | USD | 20240731 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 1052376000 | USD | 20240501 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 4563595000 | USD | 20250224 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 1169994000 | USD | 20231101 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 3403222000 | USD | 20231101 | Open filing evidence |
Revenue From Contract With Customer · Markel Ventures · Investment Management
Concentration Risk By Benchmark · Statement Business Segments · Product Or Service
Source dimensions
us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesMember;srt:ProductOrServiceAxis=mkl:InvestmentManagementMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-04-01 – 2024-06-30 | 0 | USD | 20240731 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 0 | USD | 20240731 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 0 | USD | 20231101 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 0 | USD | 20231101 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 0 | USD | 20240731 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 0 | USD | 20240731 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 0 | USD | 20231101 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 0 | USD | 20231101 | Open filing evidence |
Revenue From Contract With Customer · Markel Ventures · Services
Concentration Risk By Benchmark · Statement Business Segments · Product Or Service
Source dimensions
us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesMember;srt:ProductOrServiceAxis=mkl:ServicesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-04-01 – 2024-06-30 | 570319000 | USD | 20240731 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 1068609000 | USD | 20240731 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 569399000 | USD | 20240731 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 1055880000 | USD | 20240731 | Open filing evidence |
Revenue From Contract With Customer · Markel Ventures Operations
Concentration Risk By Benchmark · Statement Business Segments
Source dimensions
us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesOperationsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-07-01 – 2022-09-30 | 1189796000 | USD | 20221101 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 3442629000 | USD | 20221101 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 1333928000 | USD | 20220802 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 2252833000 | USD | 20220802 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 3532154000 | USD | 20220218 | Open filing evidence |
Revenue From Contract With Customer · Markel Ventures Operations · Investment Management
Concentration Risk By Benchmark · Statement Business Segments · Product Or Service
Source dimensions
us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesOperationsMember;srt:ProductOrServiceAxis=mkl:InvestmentManagementMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-04-01 – 2022-06-30 | 0 | USD | 20220802 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 0 | USD | 20220802 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 0 | USD | 20220218 | Open filing evidence |
Revenue From Contract With Customer · Markel Ventures Operations · Services
Concentration Risk By Benchmark · Statement Business Segments · Product Or Service
Source dimensions
us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesOperationsMember;srt:ProductOrServiceAxis=mkl:ServicesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-01-01 – 2021-12-31 | 1863706000 | USD | 20220218 | Open filing evidence |
Revenue From Contract With Customer · Markel Ventures Operations · Product
Concentration Risk By Benchmark · Statement Business Segments · Product Or Service
Source dimensions
us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesOperationsMember;srt:ProductOrServiceAxis=us-gaap:ProductMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-07-01 – 2022-09-30 | 575277000 | USD | 20221101 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 1809276000 | USD | 20221101 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 764543000 | USD | 20220802 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 1233999000 | USD | 20220802 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 1668448000 | USD | 20220218 | Open filing evidence |
Revenue From Contract With Customer · Other Insurance Operations
Concentration Risk By Benchmark · Statement Business Segments
Source dimensions
us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:OtherInsuranceOperationsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 22069000 | USD | 20240501 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 13313000 | USD | 20240501 | Open filing evidence |
Revenue From Contract With Customer · Other Insurance Operations · Product
Concentration Risk By Benchmark · Statement Business Segments · Product Or Service
Source dimensions
us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:OtherInsuranceOperationsMember;srt:ProductOrServiceAxis=us-gaap:ProductMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 0 | USD | 20240501 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 0 | USD | 20240501 | Open filing evidence |
Revenue From Contract With Customer · Other
Concentration Risk By Benchmark · Statement Business Segments
Source dimensions
us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:OtherMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-04-01 – 2025-06-30 | 31435000 | USD | 20250730 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 59718000 | USD | 20250730 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 28283000 | USD | 20250430 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 107419000 | USD | 20250224 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 28099000 | USD | 20241030 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 75129000 | USD | 20241030 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 24961000 | USD | 20250730 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 47030000 | USD | 20250730 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 22069000 | USD | 20250430 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 109850000 | USD | 20250224 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 47108000 | USD | 20241030 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 83650000 | USD | 20241030 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 23229000 | USD | 20240731 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 36542000 | USD | 20240731 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 13313000 | USD | 20230426 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 123084000 | USD | 20250224 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 27170000 | USD | 20231101 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 96744000 | USD | 20231101 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 28778000 | USD | 20220802 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 69574000 | USD | 20220802 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 40796000 | USD | 20230426 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 221107000 | USD | 20240223 | Open filing evidence |
Revenue From Contract With Customer · Other · Investment Management
Concentration Risk By Benchmark · Statement Business Segments · Product Or Service
Source dimensions
us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:OtherMember;srt:ProductOrServiceAxis=mkl:InvestmentManagementMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-07-01 – 2023-09-30 | 44204000 | USD | 20231101 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 76108000 | USD | 20231101 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 15641000 | USD | 20231101 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 55197000 | USD | 20231101 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 20328000 | USD | 20220802 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 39556000 | USD | 20220802 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 86257000 | USD | 20220218 | Open filing evidence |
Revenue From Contract With Customer · Other · Services
Concentration Risk By Benchmark · Statement Business Segments · Product Or Service
Source dimensions
us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:OtherMember;srt:ProductOrServiceAxis=mkl:ServicesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-01-01 – 2021-12-31 | 134850000 | USD | 20220218 | Open filing evidence |
Revenue From Contract With Customer · Other · Product
Concentration Risk By Benchmark · Statement Business Segments · Product Or Service
Source dimensions
us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:OtherMember;srt:ProductOrServiceAxis=us-gaap:ProductMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-03-31 | 0 | USD | 20230426 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 0 | USD | 20220802 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 0 | USD | 20220802 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 0 | USD | 20230426 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 0 | USD | 20220218 | Open filing evidence |
Corporate Expense
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=mkl:CorporateExpenseMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-12-31 | 0 | USD | 20250224 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 0 | USD | 20250224 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 0 | USD | 20250224 | Open filing evidence |
Insurance
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=mkl:InsuranceMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-12-31 | 7407643000 | USD | 20250224 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 7282705000 | USD | 20250224 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 6528263000 | USD | 20250224 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 5465284000 | USD | 20240223 | Open filing evidence |
Investing
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=mkl:InvestingMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-12-31 | 2772950000 | USD | 20250224 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 2241419000 | USD | 20250224 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | -1167548000 | USD | 20250224 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 2353124000 | USD | 20240223 | Open filing evidence |
Markel Ventures
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-12-31 | 5120096000 | USD | 20250224 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 4985081000 | USD | 20250224 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 1245577000 | USD | 20231101 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 3735329000 | USD | 20231101 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 1385813000 | USD | 20230802 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 2489752000 | USD | 20230802 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 1103939000 | USD | 20230426 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 4757527000 Restated | USD | 20250224 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 1215746000 | USD | 20231101 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 3527429000 | USD | 20231101 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 1361298000 | USD | 20230802 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 2311683000 | USD | 20230802 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 950385000 | USD | 20230426 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 3643827000 Restated | USD | 20240223 | Open filing evidence |
Markel Ventures · Disposition Gain
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesMember;srt:ProductOrServiceAxis=mkl:DispositionGainMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-04-01 – 2023-06-30 | 0 | USD | 20230802 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 0 | USD | 20230802 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 0 | USD | 20230217 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 0 | USD | 20230802 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 0 | USD | 20230802 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 0 | USD | 20230217 | Open filing evidence |
Markel Ventures · Investment Management · Revenue From Contract With Customer
Statement Business Segments · Product Or Service · Concentration Risk By Benchmark
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesMember;srt:ProductOrServiceAxis=mkl:InvestmentManagementMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-04-01 – 2023-06-30 | 0 | USD | 20230802 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 0 | USD | 20230802 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 0 | USD | 20230426 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 0 | USD | 20230802 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 0 | USD | 20230802 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 0 | USD | 20230426 | Open filing evidence |
Markel Ventures · Other Revenues
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesMember;srt:ProductOrServiceAxis=mkl:OtherRevenuesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-07-01 – 2023-09-30 | 62379000 | USD | 20231101 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 160282000 | USD | 20231101 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 47016000 | USD | 20230802 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 97903000 | USD | 20230802 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 50887000 | USD | 20230426 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 111806000 | USD | 20230217 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 46298000 | USD | 20231101 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 122670000 | USD | 20231101 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 36134000 | USD | 20230802 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 76372000 | USD | 20230802 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 28422000 | USD | 20230426 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 111662000 | USD | 20230217 | Open filing evidence |
Markel Ventures · Program Services And Other Fronting
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesMember;srt:ProductOrServiceAxis=mkl:ProgramServicesAndOtherFrontingMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-04-01 – 2023-06-30 | 0 | USD | 20230802 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 0 | USD | 20230802 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 0 | USD | 20230426 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 0 | USD | 20230217 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 0 | USD | 20230802 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 0 | USD | 20230802 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 0 | USD | 20230426 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 0 | USD | 20230217 | Open filing evidence |
Markel Ventures · Services · Revenue From Contract With Customer
Statement Business Segments · Product Or Service · Concentration Risk By Benchmark
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesMember;srt:ProductOrServiceAxis=mkl:ServicesMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-04-01 – 2023-06-30 | 569013000 | USD | 20230802 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 1054675000 | USD | 20230802 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 561596000 | USD | 20230802 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 999229000 | USD | 20230802 | Open filing evidence |
Markel Ventures · Product · Revenue From Contract With Customer
Statement Business Segments · Product Or Service · Concentration Risk By Benchmark
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesMember;srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-04-01 – 2023-06-30 | 770171000 | USD | 20230802 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 1336066000 | USD | 20230802 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 2379399000 | USD | 20230217 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 764543000 | USD | 20230802 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 1233999000 | USD | 20230802 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 1668448000 | USD | 20230217 | Open filing evidence |
Markel Ventures · Revenue From Contract With Customer
Statement Business Segments · Concentration Risk By Benchmark
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-12-31 | 4749915000 | USD | 20240223 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 1339184000 | USD | 20230802 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 2390741000 | USD | 20230802 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 1051557000 | USD | 20230426 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 4563595000 Restated | USD | 20240223 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 1326139000 | USD | 20230802 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 2233228000 | USD | 20230802 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 918905000 | USD | 20230426 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 3505477000 Restated | USD | 20240223 | Open filing evidence |
Markel Ventures · Revenue From Contract With Customer · Investment Management
Statement Business Segments · Concentration Risk By Benchmark · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;srt:ProductOrServiceAxis=mkl:InvestmentManagementMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-12-31 | 0 | USD | 20240223 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 0 | USD | 20240223 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 0 | USD | 20240223 | Open filing evidence |
Markel Ventures · Revenue From Contract With Customer · Services
Statement Business Segments · Concentration Risk By Benchmark · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;srt:ProductOrServiceAxis=mkl:ServicesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 2265413000 | USD | 20230217 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 1863706000 | USD | 20230217 | Open filing evidence |
Markel Ventures · Revenue From Contract With Customer · Product
Statement Business Segments · Concentration Risk By Benchmark · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;srt:ProductOrServiceAxis=us-gaap:ProductMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-12-31 | 2487054000 | USD | 20240223 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 565895000 | USD | 20230426 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 2379399000 | USD | 20240223 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 469456000 | USD | 20230426 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 1668448000 | USD | 20240223 | Open filing evidence |
Markel Ventures Operations
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesOperationsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-07-01 – 2022-09-30 | 1215746000 | USD | 20221101 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 3527429000 | USD | 20221101 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 1361298000 | USD | 20220802 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 2311683000 | USD | 20220802 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 950385000 | USD | 20220426 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 3643816000 | USD | 20220218 | Open filing evidence |
Markel Ventures Operations · Disposition Gain
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesOperationsMember;srt:ProductOrServiceAxis=mkl:DispositionGainMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-09-30 | 0 | USD | 20221101 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 0 | USD | 20220426 | Open filing evidence |
Markel Ventures Operations · Other Revenues
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesOperationsMember;srt:ProductOrServiceAxis=mkl:OtherRevenuesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-03-31 | 31480000 | USD | 20220426 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 111662000 | USD | 20220218 | Open filing evidence |
Markel Ventures Operations · Program Services And Other Fronting
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesOperationsMember;srt:ProductOrServiceAxis=mkl:ProgramServicesAndOtherFrontingMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-07-01 – 2022-09-30 | 0 | USD | 20221101 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 0 | USD | 20221101 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 0 | USD | 20220426 | Open filing evidence |
Markel Ventures Operations · Product · Revenue From Contract With Customer
Statement Business Segments · Product Or Service · Concentration Risk By Benchmark
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesOperationsMember;srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-03-31 | 469456000 | USD | 20220426 | Open filing evidence |
Markel Ventures Operations · Revenue From Contract With Customer
Statement Business Segments · Concentration Risk By Benchmark
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesOperationsMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-03-31 | 918905000 | USD | 20220426 | Open filing evidence |
Other Insurance Operations
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=mkl:OtherInsuranceOperationsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-12-31 | 291873000 | USD | 20250224 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 280131000 | USD | 20250224 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 493746000 | USD | 20250224 | Open filing evidence |
Other
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=mkl:OtherMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-12-31 | 280131000 | USD | 20240223 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 81574000 | USD | 20231101 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 192782000 | USD | 20231101 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 71360000 | USD | 20230802 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 111208000 | USD | 20230802 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 39848000 | USD | 20230426 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 493746000 Restated | USD | 20240223 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 62438000 Restated | USD | 20231101 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 280267000 Restated | USD | 20231101 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 55653000 Restated | USD | 20230802 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 217829000 Restated | USD | 20230802 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 162176000 Restated | USD | 20230426 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 342142000 Restated | USD | 20240223 | Open filing evidence |
Other · Investment Management · Revenue From Contract With Customer
Statement Business Segments · Product Or Service · Concentration Risk By Benchmark
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=mkl:OtherMember;srt:ProductOrServiceAxis=mkl:InvestmentManagementMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-04-01 – 2023-06-30 | 21445000 | USD | 20230802 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 31904000 | USD | 20230802 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 20328000 | USD | 20230802 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 39556000 | USD | 20230802 | Open filing evidence |
Other · Other Revenues
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=mkl:OtherMember;srt:ProductOrServiceAxis=mkl:OtherRevenuesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-07-01 – 2023-09-30 | -9297000 | USD | 20231101 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | -12258000 | USD | 20231101 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 407000 | USD | 20230802 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 1065000 | USD | 20230802 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | -16621000 | USD | 20230217 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 1790000 | USD | 20231101 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 10773000 | USD | 20231101 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 391000 | USD | 20230802 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 7392000 | USD | 20230802 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 8699000 Restated | USD | 20230217 | Open filing evidence |
Other · Program Services And Other Fronting
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=mkl:OtherMember;srt:ProductOrServiceAxis=mkl:ProgramServicesAndOtherFrontingMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-04-01 – 2023-06-30 | 37563000 | USD | 20230802 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 66453000 | USD | 20230802 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 147612000 | USD | 20230217 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 29731000 | USD | 20230802 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 63063000 | USD | 20230802 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 123823000 | USD | 20230217 | Open filing evidence |
Other · Product · Revenue From Contract With Customer
Statement Business Segments · Product Or Service · Concentration Risk By Benchmark
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=mkl:OtherMember;srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-04-01 – 2023-06-30 | 0 | USD | 20230802 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 0 | USD | 20230802 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 0 | USD | 20230802 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 0 | USD | 20230802 | Open filing evidence |
Other · Revenue From Contract With Customer
Statement Business Segments · Concentration Risk By Benchmark
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=mkl:OtherMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-04-01 – 2023-06-30 | 23229000 | USD | 20230802 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 36542000 | USD | 20230802 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 123084000 | USD | 20230217 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 28778000 | USD | 20230802 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 69574000 | USD | 20230802 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 221107000 | USD | 20230217 | Open filing evidence |
Other · Revenue From Contract With Customer · Investment Management
Statement Business Segments · Concentration Risk By Benchmark · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=mkl:OtherMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;srt:ProductOrServiceAxis=mkl:InvestmentManagementMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 79209000 | USD | 20230217 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 86257000 | USD | 20230217 | Open filing evidence |
Other · Revenue From Contract With Customer · Services
Statement Business Segments · Concentration Risk By Benchmark · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=mkl:OtherMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;srt:ProductOrServiceAxis=mkl:ServicesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 43875000 | USD | 20230217 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 134850000 | USD | 20230217 | Open filing evidence |
Reinsurance
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=mkl:ReinsuranceMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-12-31 | 1028201000 | USD | 20250224 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 1014294000 | USD | 20250224 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 1063347000 | USD | 20250224 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 1042048000 | USD | 20240223 | Open filing evidence |